Literature DB >> 9051292

Inhibition by rapamycin of ornithine decarboxylase and epithelial cell proliferation in intestinal IEC-6 cells in culture.

E R Seidel1, V L Ragan.   

Abstract

1. Induction of the enzyme ornithine decarboxylase (ODC) appears to be controlled primarily at the level of ODC mRNA translation. The immunosuppressant drug, rapamycin, blocked the induction of ODC in response to serum by roughly 50% but was without effect on transport of putrescine into the intracellular space. The effect on ODC was specific for the intracellular signalling pathway leading to activation of p70S6k, as the immunosuppressant FK 506 was without effect on ODC activity. 2. Exposure of IEC-6 duodenal epithelial cells to rapamycin inhibited cellular proliferation. The effect of rapamycin was cytostatic in that removal of the immunosuppressant from the medium resulted in renewed cell division. Conversely, addition of exogenous putrescine, the product of the ODC catalysed reaction, was unable to reverse the cytostatic effects of rapamycin. 3. At a concentration of 10 nM, rapamycin inhibited the induction of ODC by 50%, a level of inhibition which could not be enhanced by exposure cells to 1000 nM rapamycin. This observation suggests that other intracellular signalling pathways, in addition to the p70S6k cascade, might be involved in regulation of translation of ODC mRNA or that rapamycin does not completely inhibit p70S6k.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9051292      PMCID: PMC1564498          DOI: 10.1038/sj.bjp.0700936

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  p44/42 mitogen-activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells.

Authors:  F Flamigni; A Facchini; C Capanni; C Stefanelli; B Tantini; C M Caldarera
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

Review 2.  The complexes of mammalian target of rapamycin.

Authors:  Hongyu Zhou; Shile Huang
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

3.  Transcriptional and translational control of ornithine decarboxylase during Ras transformation.

Authors:  Lisa M Shantz
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

Review 4.  The mTOR signalling pathway in human cancer.

Authors:  Helena Pópulo; José Manuel Lopes; Paula Soares
Journal:  Int J Mol Sci       Date:  2012-02-10       Impact factor: 6.208

Review 5.  Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature.

Authors:  Wolfgang Hohenforst-Schmidt; Paul Zarogoulidis; Georgia Pitsiou; Bernd Linsmeier; Drosos Tsavlis; Ioannis Kioumis; Eleni Papadaki; Lutz Freitag; Theodora Tsiouda; J Francis Turner; Robert Browning; Michael Simoff; Nikolaos Sachpekidis; Kosmas Tsakiridis; Bojan Zaric; Lonny Yarmus; Sofia Baka; Grigoris Stratakos; Harald Rittger
Journal:  J Cancer       Date:  2016-01-13       Impact factor: 4.207

Review 6.  mTOR Cross-Talk in Cancer and Potential for Combination Therapy.

Authors:  Fabiana Conciatori; Ludovica Ciuffreda; Chiara Bazzichetto; Italia Falcone; Sara Pilotto; Emilio Bria; Francesco Cognetti; Michele Milella
Journal:  Cancers (Basel)       Date:  2018-01-19       Impact factor: 6.639

Review 7.  PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Franziska Briest; Patricia Grabowski
Journal:  Theranostics       Date:  2014-01-29       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.